Back to SUPN
Atria Investments, Inc SUPN Position History
Supernus Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$283K
Q3 2026
Peak value
$405K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $369K |
| Q4 2025 | $405K |
| Q1 2026 | $343K |
| Q2 2026 | $295K |
| Q3 2026 | $283K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $283K | 6.6K | — | — |
| Q2 2026 | $295K | 6.3K | — | — |
| Q1 2026 | $343K | 6.6K | — | — |
| Q4 2025 | $405K | 8.2K | — | — |
| Q3 2025 | $369K | 7.7K | — | — |
Other funds holding SUPN
$179.2M
$171.4M
$164.2M
$118.3M
$114.4M
$114.4M